News
Frailty assessment in patients with advanced/metastatic renal cell carcinoma using routine data collected during treatment with tyrosine kinase inhibitors in the STAR trial. ML analysis results: ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback